Table 1.

HMGA2 and let-7s expression in 35 uterine leiomyosarcomas

Case no.	Age (years)	Size (cm)	HMGA2 (IHC)	HMGA2 (RT)	Let-7c (ISH)	Let-7 (c, d, f-2)	Ki-67 index (%)
ULMS1	43	5	0		0		30
ULMS2	57	4	0		−2		15
ULMS3	55	4	0		1		50
ULMS4	53	10.5	0		0		60
ULMS5	54	11#	0		−1		50
ULMS6	79	30	0		−1		25
ULMS7	83	13	2+		−1		10
ULMS8	38	17	0		0		25
ULMS9	82	9	0		0		35
ULMS10	69	8.5	3+		1		25
ULMS11	85	?***	3+		−1		25
ULMS12	59	15	0		0		30
ULMS13	74	5	0		0		5
ULMS14	50	6.8	0		0		50
ULMS15	52	22#	3+		−2		40
ULMS16	60	12	2+		−1		15
ULMS17	55	9	0		−1		30
ULMS18	73	11	2+		−2		60
ULMS19	46	?	0		1		20
ULMS20	64	?	3+		−1		35
ULMS21	64	8	0		0		30
ULMS22	48	7	0		0		5
ULMS23	63	?	0		1
ULMS24	59	4.5	0		1		60
ULMS25	55	?	0		0		60
ULMS26	43	20	3+		0		20
ULMS27	57	12	4+		0		30
ULMS28	49	14	3+		−1		50
ULMS29	74	?	3+		−1		40
ULMS30	60	2	0
ULMS31	55	16		3		1, 0, 1
ULMS32	63	17	2*	2		2, 0, 1
ULMS33	51	20		3		3, 1, 3
ULMS34	53	21**	2*	2		1, 0, 1
ULMS35	73	12		4		2, 1, 1
Mean	59.94	11.62	1.13	2.50	−0.35	−	33.21
Sem	2.00	1.07	0.24	0.18	0.15	−	3.06

^*Western blot results.

^**Karyotype: t(12; 14) and tri(12) (see Fig. 2); IHC: immunohistochemistry; ISH: in situ hybridization.

^***: Tumour size is not documented in pathological report.

^#: Tumours with extrauterine extension.